2026 Mid-Year China Access Outlook Strategic Debrief
Rebalancing Innovation Access Under Tighter Constraints
As of mid-2026, recent and ongoing developments point to a more deliberate recalibration
China’s Healthcare System Is Reorganizing: What It Means for Manufacturers
As China’s healthcare system reorganizes, evolving care pathways and payment dynamics are reshaping how access is secured and how value is realized.
NRDL+ 2025 Annual Executive Debrief: The State of Access for Innovative Medicines in China
This Access360 Executive Briefing lays the groundwork for understanding China’s shift toward value-based pricing, deeper insurance–medicine–care integration, and broader market transformation driven by its national commercial insurance catalog initiatives.
NRDL+ 2024 Annual Executive Debrief: The State of Access for Innovative Medicines in China
In this inaugural annual NRDL+ debrief, we comprehensively examined pivotal developments and trends across basic medical insurance schemes, the commercial
